Last reviewed · How we verify
RecFSH / follitropin beta
RecFSH / follitropin beta is a Gonadotropin Biologic drug developed by Organon and Co. It is currently in Phase 3 development for Induction of ovulation and pregnancy in women with ovulatory disorders, Fertility preservation in cancer patients. Also known as: Follistim® AQ Cartridge.
RecFSH / follitropin beta stimulates the production of follicle-stimulating hormone, promoting ovulation and follicular growth.
Follitropin beta is a recombinant human follicle-stimulating hormone (r-hFSH) used in assisted reproductive technologies. It has completed several clinical trials, demonstrating efficacy and safety in ovarian stimulation for IVF. The drug is not yet FDA-approved but has potential in optimizing stimulation protocols for hypo-responders.
At a glance
| Generic name | RecFSH / follitropin beta |
|---|---|
| Also known as | Follistim® AQ Cartridge |
| Sponsor | Organon and Co |
| Drug class | Gonadotropin |
| Target | FSH receptor |
| Modality | Biologic |
| Therapeutic area | Reproductive Health |
| Phase | Phase 3 |
Mechanism of action
Follitropin beta is a recombinant human follicle-stimulating hormone (FSH) analog that mimics the action of natural FSH. It binds to FSH receptors on the surface of ovarian follicles, stimulating their growth and maturation, and promoting ovulation. This process is essential for fertility treatment in women with ovulation disorders or those undergoing assisted reproductive technologies.
Approved indications
- Induction of ovulation and pregnancy in women with ovulatory disorders
- Fertility preservation in cancer patients
Common side effects
- Ovarian hyperstimulation syndrome
- Multiple pregnancy
- Headache
- Nausea
- Injection site reaction
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- RecFSH / follitropin beta CI brief — competitive landscape report
- RecFSH / follitropin beta updates RSS · CI watch RSS
- Organon and Co portfolio CI
Frequently asked questions about RecFSH / follitropin beta
What is RecFSH / follitropin beta?
How does RecFSH / follitropin beta work?
What is RecFSH / follitropin beta used for?
Who makes RecFSH / follitropin beta?
Is RecFSH / follitropin beta also known as anything else?
What drug class is RecFSH / follitropin beta in?
What development phase is RecFSH / follitropin beta in?
What are the side effects of RecFSH / follitropin beta?
What does RecFSH / follitropin beta target?
Related
- Drug class: All Gonadotropin drugs
- Target: All drugs targeting FSH receptor
- Manufacturer: Organon and Co — full pipeline
- Therapeutic area: All drugs in Reproductive Health
- Indication: Drugs for Induction of ovulation and pregnancy in women with ovulatory disorders
- Indication: Drugs for Fertility preservation in cancer patients
- Also known as: Follistim® AQ Cartridge
- Compare: RecFSH / follitropin beta vs similar drugs
- Pricing: RecFSH / follitropin beta cost, discount & access